Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 8:2022:6343818.
doi: 10.1155/2022/6343818. eCollection 2022.

Mycoplasma pneumoniae Infections and Primary Immune Deficiencies

Affiliations
Review

Mycoplasma pneumoniae Infections and Primary Immune Deficiencies

Dimitri Poddighe et al. Int J Clin Pract. .

Abstract

Mycoplasma pneumoniae (M. pneumoniae) is one of the leading causes of community-acquired pneumonia in children and is also implicated in a variety of reactive extrapulmonary diseases. Recurrent and/or severe respiratory infections are one of the most frequent manifestations of several types of primary immunodeficiency. Here, we reviewed the medical literature to assess the potential relevance of M. pneumoniae in the infections observed in children affected with combined, humoral, and innate primary immune deficiencies. M. pneumoniae does not result to be epidemiologically prevalent as a cause of pneumonia in children affected by primary immunodeficiencies, but this infection can have a persistent or severe course in this category of patients. Indeed, the active search of M. pneumoniae could be useful and appropriate especially in children with humoral immune deficiencies. Indeed, most cases of M. pneumoniae infection in primary immunodeficiencies are described in patients affected by a/hypo-gammaglobulinemia.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

    1. Waites K. B., Talkington D. F. Mycoplasma pneumoniae and its role as a human pathogen. Clinical Microbiology Reviews . 2004;17(4):697–728. doi: 10.1128/cmr.17.4.697-728.2004. - DOI - PMC - PubMed
    1. Krafft C., Christy C. Mycoplasma pneumonia in children and adolescents. Pediatrics in Review . 2020;41(1):12–19. doi: 10.1542/pir.2018-0016. - DOI - PubMed
    1. Wood P. R., Hill V. L., Burks M. L., et al. Mycoplasma pneumoniae in children with acute and refractory asthma. Annals of Allergy, Asthma, and Immunology . 2013;110(5):328–334. doi: 10.1016/j.anai.2013.01.022. - DOI - PMC - PubMed
    1. Poddighe D. Extra-pulmonary diseases related to mycoplasma pneumoniae in children: recent insights into the pathogenesis. Current Opinion in Rheumatology . 2018;30(4):380–387. doi: 10.1097/bor.0000000000000494. - DOI - PubMed
    1. Narita M. Classification of extrapulmonary manifestations due to mycoplasma pneumoniae infection on the basis of possible pathogenesis. Frontiers in Microbiology . 2016;7:p. 23. doi: 10.3389/fmicb.2016.00023. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources